Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Stockholders to Learn More About the Investigation

Core Viewpoint - Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Keros Therapeutics, Inc. (KROS) and is encouraging stockholders to gather more information regarding the investigation [1] Group 1 - The investigation is focused on potential violations of federal securities laws by Keros Therapeutics, Inc. [1] - Stockholders are urged to contact the firm to learn more about their rights and the investigation process [1] - The investigation may involve examining the company's financial disclosures and business practices [1]